Compare CUBI & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CUBI | CLDX |
|---|---|---|
| Founded | 1994 | N/A |
| Country | United States | United States |
| Employees | 869 | N/A |
| Industry | Major Banks | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.4B |
| IPO Year | N/A | 1995 |
| Metric | CUBI | CLDX |
|---|---|---|
| Price | $75.51 | $30.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 10 |
| Target Price | ★ $85.00 | $46.60 |
| AVG Volume (30 Days) | 303.1K | ★ 631.7K |
| Earning Date | 04-23-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,743,000.00 |
| Revenue This Year | $24.95 | $111.39 |
| Revenue Next Year | $9.50 | $235.85 |
| P/E Ratio | $11.78 | ★ N/A |
| Revenue Growth | N/A | ★ 87.78 |
| 52 Week Low | $50.06 | $18.56 |
| 52 Week High | $82.56 | $35.83 |
| Indicator | CUBI | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 52.69 | 42.39 |
| Support Level | $72.29 | $28.30 |
| Resistance Level | $79.42 | $30.90 |
| Average True Range (ATR) | 1.96 | 1.45 |
| MACD | -0.17 | -0.33 |
| Stochastic Oscillator | 47.16 | 26.46 |
Customers Bancorp Inc is a bank holding company conducting banking activities through its wholly owned subsidiary, Customers Bank. The Bank provides commercial and consumer customers the stability of a regulated financial institution supported by risk management. It serves commercial and corporate businesses nationwide, including healthcare, real estate, specialty finance, fund finance, technology and venture capital banking, mortgage finance and commercial equipment financing, and provides payments and treasury services. The Bank also serves consumers through its branch network, offering residential mortgages and personal loan and deposit products, including Banking-as-a-Service, with services delivered predominantly in Southeastern and Central Pennsylvania, New York, and other states.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.